Clinical outcomes

Clinical Outcomes

Monitoring clinical outcome data is an integral part of our quality assessment. It is led by Professor Andrew Renehan, supported by a team of clinical and research data managers.

Collecting and monitoring

Since 2008, we have prospectively collected our clinical data and outcomes across three linked databases for colorectal cancer, peritoneal tumours and metastases, and anal cancer.

This data is monitored regularly through our quarterly mortality and morbidity meeting. To record complications from our operations in a standardised way, we’ve used the National Cancer Institute (CCTAE) system since 2008. We’ve also included the Clavien-Dindo classification system since 2011. This allows us to compare and demonstrate that while our major surgical cases have increased each year, our complication rates are among the lowest in the world.

The Christie outcomes

Clinical trials

We are leading experts in cancer care, research and education. Rated as ‘Outstanding’ by the health regulator, the Care Quality Commission, we have been pioneering cancer research breakthroughs for over 100 years and offer patients access to hundreds of clinical trials. In a global survey we have been ranked as the most technologically advanced cancer centre in the world outside North America.